Similar to PD patients (Fig. 2), we found that 6-OHDA, but not saline treated mice, exhibited an increased percentage of DAT+/TH+ PBMCs, with no change in total CD11b+ monocytes (Fig. 3C, D). This evidence concerns the gene SLC6A3 and Parkinson disease.